Alaunos Therapeutics Inc. Common Stock (TCRT)
Stock · NASDAQ · Health Care
$1.56as of 8/28/2026
Price chart
Open in TradingViewActive signals
About TCRT
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 1
- Website
- alaunos.com/
Fundamentals
- 1-day range
- $1.88$1.94
- Market cap
- $48.60M
- P/E (trailing)
- —
- P/E (forward)
- -3.13
- EPS (trailing)
- $-2.06
- Dividend yield
- —
- Beta
- -1.00
- Avg. volume
- 15.0K
How Alaunos Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Alaunos Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TCRTAlaunos Therapeutics Inc. Common Stock$1.56▼ 6.02%Market cap $48.60MP/E —$1.55$4.59
- IBOImpact BioMedical Inc. Common Stock$0.444▲ 0.68%Market cap $48.61MP/E 0.49$0.37$0.83
- MREOMereo BioPharma Group plc American Depositary Shares$0.2545▼ 6.43%Market cap $47.46MP/E —$0.2$2.37
- CNTXContext Therapeutics Inc. Common Stock$0.3836▼ 7.79%Market cap $46.31MP/E —$0.3807$3.62
- SCYXSCYNEXIS Inc. Common Stock$5.44▼ 1.45%Market cap $51.64MP/E —$3.53$10.48
- RNXTRenovoRx Inc. Common Stock$1.68▲ 13.18%Market cap $51.86MP/E —$0.7006$1.68
- EDSAEdesa Biotech Inc. Common Shares$4.61▲ 0.22%Market cap $44.90MP/E —
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TCRT Alaunos Therapeutics Inc. Common Stock | $48.60M | — | $1.56 | ▼ 6.02% | $1.55$4.59 |
| IBO Impact BioMedical Inc. Common Stock | $48.61M | 0.49 | $0.444 | ▲ 0.68% | $0.37$0.83 |
| MREO Mereo BioPharma Group plc American Depositary Shares | $47.46M | — | $0.2545 | ▼ 6.43% | $0.2$2.37 |
| CNTX Context Therapeutics Inc. Common Stock | $46.31M | — | $0.3836 | ▼ 7.79% | $0.3807$3.62 |
| SCYX SCYNEXIS Inc. Common Stock | $51.64M | — | $5.44 | ▼ 1.45% | $3.53$10.48 |
| RNXT RenovoRx Inc. Common Stock | $51.86M | — | $1.68 | ▲ 13.18% | $0.7006$1.68 |
| EDSA Edesa Biotech Inc. Common Shares | $44.90M | — | $4.61 | ▲ 0.22% |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Holger Weis · August 6, 2026 · Grant4.4K @ $2.01
- Michael Allen Jerman · July 23, 2026 · Grant8.1K @ $1.92
- Holger Weis · July 23, 2026 · Grant4.6K @ $1.92
- Robert W. Postma · July 23, 2026 · Grant8.5K @ $1.92
- Jaime Vieser · July 23, 2026 · Grant8.8K @ $1.92
- Holger Weis · June 30, 2026 · Grant3.9K @ $2.26
- Holger Weis · June 12, 2026 · Grant7.8K @ $2.26
- Holger Weis · May 22, 2026 · Grant3.7K @ $2.37
- Robert W. Postma · April 29, 2026 · Grant6.3K @ $2.59
- Jaime Vieser · April 29, 2026 · Grant6.5K @ $2.59
- Michael Allen Jerman · April 29, 2026 · Grant6.0K @ $2.59
Institutional Ownership
March 31, 2026
- Total shares held
- 109.9K
- Total value held
- $276.8K
- Institutional holders
- 26
- Unknown22.6K
- Unknown21.4K
- Unknown14.1K
- Unknown13.3K
- Unknown10.8K
- Unknown10.5K
- Unknown10.2K
- Unknown2.3K
- Unknown1.8K
- Unknown1.6K
See the full, filterable feed with live charts on the MarketWall dashboard.